Charisse R. Lillie - 30 Sep 2025 Form 4 Insider Report for EXELON CORP (EXC)

Role: Director
Signature: David T. Skinner, attorney-in-fact for Charisse R Lillie
Issuer symbol: EXC
Transactions as of: 30 Sep 2025
Net transactions value: +$41,258
Form type: 4
Filing time: 01 Oct 2025, 20:45:27 UTC
Previous filing: 02 Jul 2025
Next filing: 02 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Lillie Charisse R	Director	10 S DEARBORN STREET, 54TH FLOOR, CHICAGO	David T. Skinner, attorney-in-fact for Charisse R Lillie	01 Oct 2025	0001972789

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EXC	Common stock- deferred stock units	Award	$41,258	+950	+9.9%	$43.43	10,542	30 Sep 2025	By Exelon Corp. Directors Deferred Stock Unit Plan	F1
holding	EXC	Common Stock						7,246	30 Sep 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	EXC	Deferred phantom share equivalents						3,784	30 Sep 2025	Common Stock	3,784		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Balance includes 88 additional shares acquired through automatic dividend reinvestment.
F2	Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. Phantom share equivalents will be settled for cash on a 1 for 1 basis upon the termination of the reporting person's service to the board of directors.
F3	Balance includes 33 additional phantom share equivalents that were accrued to the account by the plan administrator on the ex-dividend date.